Biomarker may help predict benefits of immunotherapy

Source: Science Daily, August 2021

In recent years, immune-based treatments for cancer have buoyed the hopes of doctors and patients alike. Drugs called immune checkpoint inhibitors have provided lifesaving benefits to a growing list of people with several types of cancer, including melanoma, lung cancer, bladder cancer, and many more.

READ THE ORIGINAL FULL ARTICLE